seed
Stage
1
Investors
About
RegCell develops cell therapies aimed at restoring immune system self-tolerance to treat autoimmune diseases by leveraging the discovery of regulatory T cells to provide long-term immune balance without broadly suppressing immune function.
Explore RegCell's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.